Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Dose Ranging Study of Ferroquine With Artesunate in African Adults and Children With Uncomplicated Plasmodium Falciparum Malaria (FARM)

This study has been terminated.
(Company decision to modify the ferroquine development strategy; discontinuation not due to safety or activity unexpected findings)
Sponsor:
Information provided by:
Sanofi
ClinicalTrials.gov Identifier:
NCT00988507
First received: October 1, 2009
Last updated: June 27, 2011
Last verified: June 2011